Cargando…
Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease
BACKGROUND: Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. AIM: To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation t...
Autores principales: | Calafat, Margalida, González-Muñoza, Carlos, Fortuny, Marta, Roig, Cristina, Calm, Anna, Mombiela, Antonio, Cañete, Fiorella, Bertoletti, Federico, González-González, Laura, Teller-Martín, Marta, Gordillo, Jordi, Mañosa, Míriam, Garcia-Planella, Esther, Domènech, Eugeni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221095/ https://www.ncbi.nlm.nih.gov/pubmed/34164799 http://dx.doi.org/10.1007/s40520-021-01917-9 |
Ejemplares similares
-
Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic
por: Iborra, Ignacio, et al.
Publicado: (2021) -
Editorial: Postoperative management of Crohn's disease: One size does not fit all
por: Domènech, Eugeni, et al.
Publicado: (2023) -
Optimizing post-operative Crohn’s disease treatment
por: Domènech, Eugeni, et al.
Publicado: (2014) -
Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis
por: Cañete, Fiorella, et al.
Publicado: (2020) -
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study
por: Guerra, Ivan, et al.
Publicado: (2023)